Holen Sie sich die Stockscreener-App
1.33
5.00%
-0.07
Handel nachbörslich:
1.33
Autolus Therapeutics Plc Adr Aktie (AUTL) Neueste Nachrichten
For Autolus Therapeutics plc ADR [AUTL], Analyst sees a rise to $7.60. What next? - dbtnews.com
UK approves Autolus leukemia therapy with conditions - Investing.com
HXL Shares Experience Surge in Value - knoxdaily.com
Market cap of i-80 Gold Corp [IAUX] reaches 279.54M – now what? - dbtnews.com
Daiwa Securities lifts Bilibili Inc ADR [BILI] price estimate. Who else is bullish? - dbtnews.com
Market Watch: Autolus Therapeutics plc ADR (AUTL)’s Noteworthy Gain, Closing at 1.60 - DWinneX
It makes sense and dollars to buy Autolus Therapeutics plc ADR (AUTL) stock - Sete News
How does PROG Holdings Inc (PRG) change from a tortoise to a hare? - Sete News
Investors in cash trouble should check out BBB Foods Inc (TBBB) - Sete News
Take off with Energous Corp (WATT): Get ready for trading - Sete News
The growth track for Protalix BioTherapeutics Inc (PLX) has changed recently - Sete News
Tokio Marine Holdings, Inc. Sponsored ADR (OTCMKTS:TKOMY) Short Interest Update - Defense World
Autolus Therapeutics to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025 - GlobeNewswire Inc.
PSQ Holdings Inc (PSQH) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Truist cuts Autolus stock price target to $10, maintains buy rating By Investing.com - Investing.com South Africa
Truist cuts Autolus stock price target to $10, maintains buy rating - Investing.com India
Agilent tech aids in FDA approval of Autolus CAR T therapy By Investing.com - Investing.com South Africa
Arhaus Inc (NASDAQ: ARHS)’s Stock Adds 0.70%, Making It A Good Investment - Stocks Register
Agilent tech aids in FDA approval of Autolus CAR T therapy - Investing.com UK
Truist maintains $11 target on Autolus stock amid strong demand By Investing.com - Investing.com South Africa
Mizuho maintains $12 target on Autolus stock after Q4 update - Investing.com India
Autolus reports progress in commercial launch and financials By Investing.com - Investing.com South Africa
Truist maintains $11 target on Autolus stock amid strong demand - Investing.com India
Autolus reports progress in commercial launch and financials - Investing.com India
Earnings call transcript: Autolus Therapeutics Q4 2024 earnings and market reaction By Investing.com - Investing.com South Africa
Autolus at Leerink’s Global Healthcare Conference: Strategic Moves in CAR T Therapy - Investing.com
10 Best UK Growth Stocks to Buy Now - Insider Monkey
Stock Surge: Autolus Therapeutics plc ADR (AUTL) Closes at 1.82, Marking a 1.68 Increase/Decrease - The Dwinnex
It would be worthwhile to take a closer look at Autolus Therapeutics plc ADR (AUTL) - US Post News
Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News
Autolus Therapeutics plc ADR (AUTL) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Autolus Therapeutics plc ADR [AUTL] Officer makes an insider purchase of 698,741 shares worth 2.96 million. - Knox Daily
Lowe’s Cos., Inc Inc. (LOW) Price Performance: The Role of Supply and Demand - The InvestChronicle
Avinger Inc [AVGR] Records 50-Day SMA of $0.7054 - Knox Daily
Floor & Decor Holdings Inc [FND] Shares Rise 0.52 % on Thursday - Knox Daily
GS Shares Experience Surge in Value - Knox Daily
Crown Holdings, Inc [CCK] Shares Fall Approximately -1.11% Over the Year - Knox Daily
VRDN Stock Sees Decline of Approximately -7.82% in Last Five Days - Knox Daily
There is no doubt that Nurix Therapeutics Inc (NRIX) ticks all the boxes. - SETE News
Enovis Corp (ENOV) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News
Check Out TC BioPharm (Holdings) plc ADR (TCBP)’s Trade Data Rather Than the Analysts’ Views - SETE News
You might want to take a look at Autolus Therapeutics plc ADR (AUTL) now - SETE News
Clean Energy Fuels Corp (CLNE)’s stock rises to 3.45 per share - US Post News
Adc Therapeutics SA (ADCT) stock analysis: A comprehensive overview - US Post News
GH Research PLC (GHRS) stock: A year of ups and downs - US Post News
Calumet Inc (CLMT)’s stock price range in the last year - US Post News
A closer look at Autolus Therapeutics plc ADR (AUTL)’s stock price trends - US Post News
Quarterly Snapshot: Quick and Current Ratios for Autolus Therapeutics plc ADR (AUTL) - The Dwinnex
Balance Sheet Insights: Edison International (EIX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Selling Your Standard Lithium Ltd (AMEX: SLI) Stock? Here’s What You Need To Know - Stocks Register
Autolus presents new data on CAR-T therapy cost benefits - Investing.com
Autolus' AUCATZYL Shows Superior Cost-Effectiveness and 84% Deep Remission Rate in Latest Data - StockTitan
A Stock Analysis Of Autolus Therapeutics plc ADR’s (AUTL) - Stocks Register
MicroAlgo Inc’s (MLGO) -2.91% Drop Is A Reason To Reconsider. - Stocks Register
Aspen Aerogels Inc (ASPN) Strikes $14.34: The Risk Seems Worthwhile At This Price - Stocks Register
Autolus reports high response in leukemia study - Investing.com India
CommScope Holding Company Inc (COMM) Is A Good Investment At Current Valuations - Stocks Register
Autolus Therapeutics plc ADR (AUTL) Has A Gold Mine On Its Hands - Stocks Register
These Numbers Prove Just How Vibrant The Ocugen Inc (NASDAQ: OCGN) Stock Has Been - Stocks Register
Autolus stock upgraded as obe-cel approval drives optimism for commercial potential - Investing.com
Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - Barchart
FDA approves new CAR-T competitor to Gilead’s Tecartus - BioPharma Dive
0.24%
36.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):